Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs GRMN✓SelectedUSD · GRMNGSK vs GRMN performance historyLatest closeAs of-1.34%11/18
Stock and ETF performance explorer

GSK vs GRMN

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+55.4%
GRMN return
+146.7%
Excess return
-91.3%
Maximum drawdown
-28.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGRMNExcessAlpha
1D-1.3%+0.8%-2.1%-1.4%
7D-3.1%-4.9%+1.8%-2.9%
30D-0.9%-2.3%+1.4%-0.8%
3M-4.2%-5.7%+1.5%-4.0%
6M-1.6%+24.2%-25.8%-2.4%
YTD+2.6%+39.5%-36.9%+1.7%
1Y+6.2%+49.7%-43.4%+5.3%
All+55.4%+146.7%-91.3%+43.4%

Cumulative growth

Daily Returns

Daily percentage return beside GRMN.

Daily Out/Under-Performance

Portfolio return minus GRMN return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GRMN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GRMN wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling